51 GHP Q2 2025 lthough Accertis provides a wide range of services to clients across multiple business areas – including consulting, product performance, and support divisions – at the heart of the firm is the simple commitment to improve its customers’ performance in the prescription market. As for how it achieves this, Accertis is guided by two key principles. The first is to lead the teams of its clients in such a way that they are empowered to discover a solution themselves, the second sees Accertis keep its business and ethical standards at industry-high levels. On the back of these principles, Accertis’ distinction in this space is obvious, with all of its mandates resulting in demonstrable improvements in sales performance, making impact easy to measure for both its clients and the firm itself. Martin explains: “In all cases over the last ten years we see such an improvement, some even dramatically. Not a lot of consulting companies can prove such a success rate.” These words ring especially true in this market, due to it being both highly specialised and deeply regulated. Traversing this complex industry landscape with relative ease, Accertis’ almost two decades of experience in this area of consulting afford it the leverage it needs to remain a frontrunner. This 20-year period has seen the team come to nurture a deep understanding of the market as well as the scientific data that drives it, leading to the realisation that intensely collaborative work is the way forwards. Close collaboration leads to the development of a strategic, fully aligned framework, paving the way for first-class execution a little down the line. Further exploring the relationship between Accertis’ strategic framework and the chances of significant sales increases being seen by clients, Martin told us: “A strategic framework must be positioned to offer patients more benefits than the major competitors, and this is often based on meticulous workups of the results of clinical trials.” Martin continued: “Second, when establishing a focused strategy, the implementation chances of high-level tactics – especially where the sales force and MSL are concerned – must be thought of.” If the utmost care is not taken in these areas, what Martin usually sees from firms is a gap in logic between strategy and the implementation at a customer level. The result is an ineffective and milking strategy type, which overrules whatever the initial focus strategy laid out during the planning sessions might have been. Accertis helps clients to avoid these pitfalls and create impactful, results-driven strategies designed to position their pharmaceutical products at the forefront of this dynamic industry. Europe’s premier pharma consulting group, Accertis’ area of expertise lines in strategic and operational consulting services for the pharmaceutical market, with the great work the firm does being defined by success, innovation, and performance improvement. By seamlessly blending an uncontested knowledge of the market with the advisory skills of its expert team, headed up by Managing Director Martin Weilenmann, Accertis is more than deserving of being named as the Best Strategic Pharmaceutical Market Consultancy Firm 2025 – Europe. We caught up with Martin to learn more. Results-Driven Pharma Consulting Thus, with its proven specialists being available at any time, the forward-looking solutions it creates in collaboration with clients to boot, and the high level of successful implementation it boasts, it should comes as no surprise that the vast majority of the businesses Accertis works with are in the pharma top ten in countries such as Germany, Switzerland, Austria and those in Scandinavia. After just a few months of partnering with Accertis, these enterprises already see great results, with these only continuing throughout the duration of the relationship. Beyond just the “partnership for success” that the firm provides, clients also benefit from the network of industry-leading experts Accertis is able to draw from, as well as the management of Martin himself. Bringing more than 20 years of leadership experience to the table, working for organisations including Pfizer Switzerland no less, Martin’s prowess in everything from sales and strategy to marketing and business planning not only inspires the rest of his team, it sets Accertis – as well as its clients – up for success on a daily basis. Masters of sales performance and successful product strategy, Martin and the team behind the acclaimed pharmaceutical consultancy firm Accertis have a successful track record when it comes to boosting brand team efficiency and positioning their clients favourably. For this, we are proud to recognise the firm with this title and a place in this feature. Contact: Martin Weilenmann Company: Accertis Web Address: https://www.accertis.ch/index.php/en/ A Feb25310
RkJQdWJsaXNoZXIy NTY1MjM3